ANLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Adlai Nortye Group Ltd.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 10, 2026
$10.38−0.65 (-5.89%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Adlai Nortye statistics
Financials through Dec 31, 2025, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Adlai Nortye | Industry median |
|---|---|---|
| Market Cap | $415.20M | $166.30M |
| Enterprise Value | $431.73M | $88.19M |
| PS Ratio | 83.04 | 3.65 |
Enterprise value
| Measure | Adlai Nortye | Industry median |
|---|---|---|
| EV / Sales | 86.35 | 2.51 |
Income (trailing twelve months)
| Measure | Adlai Nortye | Industry median |
|---|---|---|
| Revenue | $5.00M | $58.34M |
| Operating Income | -$35.70M | -$21.40M |
| Pretax Income | -$35.53M | -$14.34M |
| Net Income | -$35.53M | -$22.46M |
| EBITDA | -$35.22M | -$16.91M |
| EPS (Diluted) | -$0.37 | -$0.83 |
Margins
| Measure | Adlai Nortye | Industry median |
|---|---|---|
| Operating Margin | -714.0% | -44.0% |
| Pretax Margin | -710.6% | -13.3% |
| Profit Margin | -710.6% | -40.2% |
| EBITDA Margin | -704.4% | -30.2% |
| FCF Margin | -672.8% | -9.27% |
Returns
| Measure | Adlai Nortye | Industry median |
|---|---|---|
| Return on Assets (ROA) | -67.2% | -40.9% |
Balance sheet
| Measure | Adlai Nortye | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $8.06M | $61.43M |
| Total Debt | $24.58M | $118.52M |
| Net Cash (Debt) | -$16.53M | $15.35M |
| Net Cash Per Share | -$0.14 | $0.66 |
| Working Capital | -$14.74M | $76.81M |
Financial position
| Measure | Adlai Nortye | Industry median |
|---|---|---|
| Current Ratio | 0.65 | 3.34 |
| Quick Ratio | 0.19 | 2.44 |
| Interest Coverage | -23.32 | -6.26 |
Cash flow (trailing twelve months)
| Measure | Adlai Nortye | Industry median |
|---|---|---|
| Operating Cash Flow | -$33.45M | -$12.35M |
| Capital Expenditures | -$187.00K | -$1.08M |
| Free Cash Flow | -$33.64M | -$20.22M |
| FCF Per Share | -$0.28 | -$0.42 |
Efficiency
| Measure | Adlai Nortye | Industry median |
|---|---|---|
| Asset Turnover | 0.09 | 0.39 |
Dividends and yields
| Measure | Adlai Nortye | Industry median |
|---|---|---|
| Earnings Yield | -8.56% | -23.3% |
| FCF Yield | -8.10% | -8.72% |
Shares
| Measure | Adlai Nortye | Industry median |
|---|---|---|
| Shares Outstanding | 120,001,000 | 58,127,000 |
| Shares Change (YoY) | 0.15% | 10.9% |
| Float | 102,405,000 | 49,136,700 |
| Shares Held by Insiders | 14.7% | 11.6% |
| Shares Held by Institutions | 22.1% | 59.4% |
Scores
| Measure | Adlai Nortye | Industry median |
|---|---|---|
| Altman Z-Score | -16.86 | -0.22 |
| Piotroski F-Score | 1 | 4 |
Calculated by StockData from Adlai Nortye's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.